The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis.

D. Ribatti, A. Vacca, L. Roncali, F. Dammacco

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Anti-angiogenesis, i.e. inhibition of blood vessel growth, is being investigated as a way to prevent the growth of tumors and other angiogenesis-dependent diseases. Pharmacological inhibition interferes with the angiogenic cascade or the immature neovasculature with synthetic or semi-synthetic substances, endogenous inhibitors or biological antagonists. The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane commonly used in vivo to study both new vessel formation and its inhibition in response to tissues, cells, or soluble factors. Angiogenesis or anti-angiogenesis is evaluated quantitatively or semiquantitatively. The fields of application of CAM in the study of anti-angiogenesis, including our personal experience, are illustrated in this paper.

Original languageEnglish
Pages (from-to)73-82
Number of pages10
JournalCurrent Pharmaceutical Biotechnology
Volume1
Issue number1
Publication statusPublished - Jul 2000

Fingerprint

Chorioallantoic Membrane
Chick Embryo
Extraembryonic Membranes
Growth
Research
Blood Vessels
Pharmacology
Neoplasms

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Biotechnology

Cite this

The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. / Ribatti, D.; Vacca, A.; Roncali, L.; Dammacco, F.

In: Current Pharmaceutical Biotechnology, Vol. 1, No. 1, 07.2000, p. 73-82.

Research output: Contribution to journalArticle

Ribatti, D. ; Vacca, A. ; Roncali, L. ; Dammacco, F. / The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. In: Current Pharmaceutical Biotechnology. 2000 ; Vol. 1, No. 1. pp. 73-82.
@article{15e2ced3a4064920a3f915ae7885145c,
title = "The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis.",
abstract = "Anti-angiogenesis, i.e. inhibition of blood vessel growth, is being investigated as a way to prevent the growth of tumors and other angiogenesis-dependent diseases. Pharmacological inhibition interferes with the angiogenic cascade or the immature neovasculature with synthetic or semi-synthetic substances, endogenous inhibitors or biological antagonists. The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane commonly used in vivo to study both new vessel formation and its inhibition in response to tissues, cells, or soluble factors. Angiogenesis or anti-angiogenesis is evaluated quantitatively or semiquantitatively. The fields of application of CAM in the study of anti-angiogenesis, including our personal experience, are illustrated in this paper.",
author = "D. Ribatti and A. Vacca and L. Roncali and F. Dammacco",
year = "2000",
month = "7",
language = "English",
volume = "1",
pages = "73--82",
journal = "Current Pharmaceutical Biotechnology",
issn = "1389-2010",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis.

AU - Ribatti, D.

AU - Vacca, A.

AU - Roncali, L.

AU - Dammacco, F.

PY - 2000/7

Y1 - 2000/7

N2 - Anti-angiogenesis, i.e. inhibition of blood vessel growth, is being investigated as a way to prevent the growth of tumors and other angiogenesis-dependent diseases. Pharmacological inhibition interferes with the angiogenic cascade or the immature neovasculature with synthetic or semi-synthetic substances, endogenous inhibitors or biological antagonists. The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane commonly used in vivo to study both new vessel formation and its inhibition in response to tissues, cells, or soluble factors. Angiogenesis or anti-angiogenesis is evaluated quantitatively or semiquantitatively. The fields of application of CAM in the study of anti-angiogenesis, including our personal experience, are illustrated in this paper.

AB - Anti-angiogenesis, i.e. inhibition of blood vessel growth, is being investigated as a way to prevent the growth of tumors and other angiogenesis-dependent diseases. Pharmacological inhibition interferes with the angiogenic cascade or the immature neovasculature with synthetic or semi-synthetic substances, endogenous inhibitors or biological antagonists. The chick embryo chorioallantoic membrane (CAM) is an extraembryonic membrane commonly used in vivo to study both new vessel formation and its inhibition in response to tissues, cells, or soluble factors. Angiogenesis or anti-angiogenesis is evaluated quantitatively or semiquantitatively. The fields of application of CAM in the study of anti-angiogenesis, including our personal experience, are illustrated in this paper.

UR - http://www.scopus.com/inward/record.url?scp=0034232194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034232194&partnerID=8YFLogxK

M3 - Article

C2 - 11467363

AN - SCOPUS:0034232194

VL - 1

SP - 73

EP - 82

JO - Current Pharmaceutical Biotechnology

JF - Current Pharmaceutical Biotechnology

SN - 1389-2010

IS - 1

ER -